March, 2020

article thumbnail

How Digital Transformation Is Affecting The Pharma And Healthcare Industry?

Fossil Remedies

Digitalization is the new buzzword. It touches each and every aspect of our lives. How is it possible that the pharma and healthcare industry remains unaffected by it? In fact, being a technology-driven industry, it gets the most benefits of digital transformation. There are digital modes for better patient care. There are people willing to receive treatment and healthcare using the digital platform.

article thumbnail

The Potential Impact of Coronavirus (COVID-19) for Global Pharma and Biotech Con

pharmaphorum

Overview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Healthcare systems are being put under significant pressure, at a time when many are already over-stretched, medical congresses are being cancelled and bans on non-essential travel and enforced home working are emerging.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Are The Traits Of A Successful Pharmacist?

indispensable health

Considering A Career In Pharmacy? All jobs intrinsically require more than the surface skills required. For example, a great teacher should not only have a bachelor's degree in education they should also have strong interpersonal skills to allow them to effectively teach. In an effort to define what makes a successful pharmacist, we asked three of our Indispensable Health pharmacists, “In Your Experience, What Are The Traits of Successful Pharmacists?

article thumbnail

Fluvoxamine Drug Interactions

Med Ed 101

Fluvoxamine drug interactions can be clinically significant in clinical practice. It is a major reason why this medication is not used very often. If you ever see it on a medication list of one of your patients, you must do a drug interaction screen. According to the package insert, fluvoxamine can inhibit CYP1A2, CYP2C9, CYP3A4, […]. The post Fluvoxamine Drug Interactions appeared first on Med Ed 101.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How ‘thinking modular’ might ease digital content overload in pharma

pharmaphorum

Overview In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based on their target product profile alone. Instead, the key factor now is often the quality of customer engagement, which more and more healthcare professionals (HCPs) appear to value. It’s enabled by a multichannel marketing (MCM) approach, but traditional MCM strategies require a much higher level of content than pharma is used to producing and approving – the answe

article thumbnail

Hydroxychloroquine Clinical Pearls – COVID-19 Buzz

Med Ed 101

The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is classified as an antimalarial agent, the most common, long term use for hydroxychloroquine that […].

40

More Trending

article thumbnail

One Time Only! 50% Off 2020 NAPLEX Content

Med Ed 101

Hey all, thanks so much for supporting the blog as well as the podcast! I’m amazed at how many people come to pick up a few pearls or listen to the drug of the week. Because of your support, I like to give annual sweet deals on our content! Today is the day for our […]. The post One Time Only! 50% Off 2020 NAPLEX Content appeared first on Med Ed 101.

40
article thumbnail

2 Common Mistakes With Acetaminophen

Med Ed 101

Many patients will take acetaminophen for their pain management. It is cheap, somewhat effective, and typically pretty safe at normal dosages. There are potential downsides when it comes to acetaminophen. Let me outline a couple of common mistakes with acetaminophen. #1 Common Mistakes with Acetaminophen – Multiple Sources Many elderly patients do understand that acetaminophen […].

Dosage 40
article thumbnail

Tapering Benzodiazepines – Tricks of the Trade

Med Ed 101

Tapering benzodiazepines or any drug for that matter is a bit of an art. Sure we do have some evidence on these types of topics, but we can’t also schedule a taper schedule perfectly based upon a percentage of the dose. Dosage forms and the patients themselves can throw a wrinkle into what we might […]. The post Tapering Benzodiazepines – Tricks of the Trade appeared first on Med Ed 101.

Dosage 40
article thumbnail

Starting Bisphosphonates in Patients With Limited Life Expectancy

Med Ed 101

I received a question the other day about the use of bisphosphonates in patients who may have a limited life expectancy but have osteoporosis or are at risk for osteoporosis. It is a very good question and that determination is going to be made on a case by case basis. Arguably the biggest challenge with […]. The post Starting Bisphosphonates in Patients With Limited Life Expectancy appeared first on Med Ed 101.

40
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.